Page 199 - HIV/AIDS Guidelines
P. 199

Table 15a. Drug Interactions between Protease Inhibitors* and Other Drugs  (Page 11 of 11)


             Concomitant        PI       Effect on PI or Concomitant Drug   Dosing Recommendations and Clinical
                 Drug                            Concentrations                          Comments

             Miscellaneous Interactions
                           All PIs      RTV 100 mg BID ↑ colchicine AUC 296%,  For treatment of gout flares
                                        C max  184%                       Colchicine 0.6 mg x 1 dose, followed by 0.3 mg 1
                                                                          hour later. Do not repeat dose for at least 3 days.
                                        With all PIs: significant ↑ in colchicine  With FPV without RTV: 1.2 mg x 1 dose and no
                                        AUC expected
                                                                          repeat dose for at least 3 days
                                                                          For prophylaxis of gout flares
                                                                          Colchicine 0.3 mg once daily or every other day
                                                                          With FPV without RTV: colchicine 0.3 mg BID or
                                                                          0.6 mg once daily or 0.3 mg once daily
             Colchicine
                                                                          For treatment of familial Mediterranean fever
                                                                          Do not exceed colchicine 0.6 mg once daily or 0.3
                                                                          mg BID.
                                                                          With FPV without RTV: Do not exceed 1.2 mg
                                                                          once daily or 0.6 mg BID.
                                                                          Do not coadminister in patients with hepatic or
                                                                          renal impairment.



             Salmeterol    All PIs      ↑ salmeterol possible             Do not coadminister because of potential
                                                                          increased risk of salmeterol-associated
                                                                          cardiovascular events, including QT prolongation,
                                                                          palpitations, and sinus tachycardia.

             Atovaquone/   ATV/r, LPV/r  ATV/r ↓ atovaquone AUC 46% and   No dosage recommendation. Consider alternative
             proguanil                  ↓ proguanil AUC 41%               drug for malaria prophylaxis, if possible.
                                        LPV/r ↓ atovaquone AUC 74% and
                                        ↓ proguanil AUC 38%



            a
             The following products contain at least 35 mcg of ethinyl estradiol combined with norethindrone or norgestimate (generic formulation may
             also be available): Ovcon 35, 50; Femcon Fe; Brevicon; Modicon; Ortho-Novum 1/35, 10/11, 7/7/7; Norinyl 1/35; Tri-Norinyl; Ortho-Cyclen;
             Ortho Tri-Cyclen.
            b
             The following products contain no more than 30 mcg of ethinyl estradiol combined with norethindrone or norgestimate (generic formulation
             may also be available): Loestrin 1/20, 1.5/30; Loestrin Fe 1/20, 1.5/30; Loestrin 24 Fe; Ortho Tri-Cyclen Lo.
            c
             Norbuprenorphine is an active metabolite of buprenorphine.
            d
             R-methadone is the active form of methadone.
            Key to Abbreviations: APV = amprenavir, ART = antiretroviral therapy, ARV = antiretroviral, ATV = atazanavir, ATV/r = atazanavir + ritonavir,
            AUC = area under the curve, BID = twice daily, CCB = calcium channel blocker, C max  = maximum plasma concentration, C min  = minimum
            plasma concentration, CNS = central nervous system, CrCl = creatinine clearance, CYP = cytochrome P, DRV = darunavir,
            DRV/r = darunavir + ritonavir, ECG = electrocardiogram, FDA = Food and Drug Administration, FPV = fosamprenavir (FPV is a prodrug of APV),
            FPV/r = fosamprenavir + ritonavir, IDV = indinavir, INR = international normalized ratio, LPV = lopinavir, LPV/r = lopinavir + ritonavir,
            NFV = nelfinavir, PAH = pulmonary arterial hypertension, PDE5 = phosphodiesterase type 5, PI = protease inhibitor, PK = pharmacokinetic,
            PPI = proton pump inhibitor, RTV = ritonavir, SQV = saquinavir, SQV/r = saquinavir + ritonavir, TCA = tricyclic antidepressant, TDF = tenofovir,
            TID = three times a day, TPV = tipranavir, TPV/r = tipranavir + ritonavir, VPA = valproic acid





            Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents        K-29

                            Downloaded from http://aidsinfo.nih.gov/guidelines on 12/8/2012 EST.
   194   195   196   197   198   199   200   201   202   203   204